Working… Menu

A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) (EP1090)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00532974
Recruitment Status : Unknown
Verified December 2007 by Epimmune.
Recruitment status was:  Active, not recruiting
First Posted : September 21, 2007
Last Update Posted : December 24, 2007
Pharmexa A/S
Information provided by:

No Study Results Posted on for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Estimated Study Completion Date : April 2008